These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Hepatic lesions associated with antimicrosomal antibodies of the liver and kidney (type 2) and the taking of tienilic acid. A study of 37 cases]. Lafay JP; Poupon R; Legendre C; Homberg JC; Darnis F Gastroenterol Clin Biol; 1983 May; 7(5):523-8. PubMed ID: 6873565 [No Abstract] [Full Text] [Related]
3. [Tienilic acid as a likely cause of "auto immune" active hepatitis (author's transl)]. Eugène C; Patriarche C; Bergue A; Quevauvilliers J Nouv Presse Med; 1980 Jun; 9(27):1885-7. PubMed ID: 6157146 [TBL] [Abstract][Full Text] [Related]
4. A new anti-liver-kidney microsome antibody (anti-LKM2) in tienilic acid-induced hepatitis. Homberg JC; Andre C; Abuaf N Clin Exp Immunol; 1984 Mar; 55(3):561-70. PubMed ID: 6368059 [TBL] [Abstract][Full Text] [Related]
5. [Tienilic acid can induce acute hepatitis, chronic hepatitis and cirrhosis. A report of three cases (author's transl)]. Pariente EA; André C; Zafrani ES; Métreau JM; Dhumeaux D; Berthelot P Gastroenterol Clin Biol; 1981 May; 5(5):567-71. PubMed ID: 7250606 [No Abstract] [Full Text] [Related]
6. [Hepatitis during treatment with tienilic acid (author's transl)]. Bousquet O; Saigot T; Bernard P; Gerbal JL; Sarrazin A Therapie; 1980; 35(2):205-8. PubMed ID: 7414529 [No Abstract] [Full Text] [Related]
8. Human anti-endoplasmic reticulum autoantibodies appearing in a drug-induced hepatitis are directed against a human liver cytochrome P-450 that hydroxylates the drug. Beaune P; Dansette PM; Mansuy D; Kiffel L; Finck M; Amar C; Leroux JP; Homberg JC Proc Natl Acad Sci U S A; 1987 Jan; 84(2):551-5. PubMed ID: 3540968 [TBL] [Abstract][Full Text] [Related]
9. [Chronic hepatitis with elevated level of endoplasmic anti-reticulum antibodies: alpha-methyldopa or tienilic acid?]. Beaugrand M; Gavillon C; Ferrier JP Gastroenterol Clin Biol; 1981; 5(8-9):819-20. PubMed ID: 7297821 [No Abstract] [Full Text] [Related]
16. [High levels of endoplasmic reticulum antibody titer in a case of alpha-methyldopa-induced chronic active hepatitis (author's transl)]. Beaugrand M; Gavillon C; Ferrier JP Gastroenterol Clin Biol; 1980 Mar; 4(3):219-21. PubMed ID: 7380145 [No Abstract] [Full Text] [Related]
17. [Acute renal failure after administration of tienilic acid (author's transl)]. Dracon M; Dequiedt P; Desprez T; Lemaitre V; Noel JL; Lelievre G; Tacquet A Therapie; 1981; 36(1):47-53. PubMed ID: 7233372 [No Abstract] [Full Text] [Related]
18. Drug-induced hepatitis associated with anticytoplasmic organelle autoantibodies. Homberg JC; Abuaf N; Helmy-Khalil S; Biour M; Poupon R; Islam S; Darnis F; Levy VG; Opolon P; Beaugrand M Hepatology; 1985; 5(5):722-7. PubMed ID: 4029887 [TBL] [Abstract][Full Text] [Related]
19. Hepatotoxicity associated with ticrynafen--a uricosuric diuretic. Manier JW; Chang WW; Kirchner JP; Beltaos E Am J Gastroenterol; 1982 Jun; 77(6):401-4. PubMed ID: 7091125 [TBL] [Abstract][Full Text] [Related]
20. Specificity of in vitro covalent binding of tienilic acid metabolites to human liver microsomes in relationship to the type of hepatotoxicity: comparison with two directly hepatotoxic drugs. Lecoeur S; Bonierbale E; Challine D; Gautier JC; Valadon P; Dansette PM; Catinot R; Ballet F; Mansuy D; Beaune PH Chem Res Toxicol; 1994; 7(3):434-42. PubMed ID: 8075377 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]